Breast Cancer
Erika Hamilton, MD
Breast Cancer
Erika Hamilton, MD
SCRI, will deliver “Efficacy and Safety of Tucatinib vs Placebo Combined with Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+ Metastatic Breast Cancer by Stratified Subgroups,” in an oral presentation on Tuesday, June 2 at 11:09 a.m. CDT as part of the session, Breast Cancer—Metastatic in Hall D1.
Click here to learn more about Dr. Hamilton.